Skip to Main Content

Author Details

Richard P Hill
Princess Margaret Cancer Centre
1968
277
69
PMIDPaper TitleJournal TitlePublished Year
35978831Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas.Front Oncol2022
35576920Modeling the impact of spatial oxygen heterogeneity on radiolytic oxygen depletion during FLASH radiotherapy.Phys Med Biol2022
33771702The Oral CXCR4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical Cancer Treated With Radiation Therapy and Concurrent Chemotherapy.Int J Radiat Oncol Biol Phys2021
32005829Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy.Sci Rep2020
30958759Peggy Louise Olive.Radiat Res2019
31650046Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?Clin Transl Radiat Oncol2019
31399696Correction: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.Br J Cancer2019
29417588Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.Int J Cancer2018
27416998The changing paradigm of tumour response to irradiation.Br J Radiol2017
29594218The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP).Clin Transl Radiat Oncol2017
28619042Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.BMC Cancer2017
28557630The Exploitation of Low-Energy Electrons in Cancer Treatment.Radiat Res2017
27901496Cancer initiating-cells are enriched in the CA9 positive fraction of primary cervix cancer xenografts.Oncotarget2017
27875522Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.Br J Cancer2017
27697997Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy.Clin Cancer Res2017
27248663Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.Oncotarget2016
26547383Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study.Int J Radiat Oncol Biol Phys2016
27292024Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors.Neoplasia2016
27318680Cancer Stem Cells.Recent Results Cancer Res2016
25042623Single-cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry.Int J Cancer2015
26384274Hypoxia and Predicting Radiation Response.Semin Radiat Oncol2015
26325106Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole.Br J Cancer2015
25842967Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells.Radiother Oncol2015
25880806Developing a prognostic micro-RNA signature for human cervical carcinoma.PLoS One2015
25944123Chromosomal instability as a prognostic marker in cervical cancer.BMC Cancer2015
25473903The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer.Oncotarget2015
25348321Establishment of orthotopic primary cervix cancer xenografts.Methods Mol Biol2015
23904154High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone.Int J Cancer2014
24811314Tumour control probability in cancer stem cells hypothesis.PLoS One2014
24820020VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma.Cancer Res2014
24759636MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.Neuro Oncol2014
24844374Hypoxia as a biomarker for radioresistant cancer stem cells.Int J Radiat Biol2014
24867538Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage.Int J Radiat Oncol Biol Phys2014
24894165Hypoxia signaling and the metastatic phenotype.Curr Mol Med2014
23278134Notes from the editors.Int J Radiat Biol2013
24045183Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3.Clin Cancer Res2013
24194929Proteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types.PLoS One2013
23856487Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.Radiother Oncol2013
23861821MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.PLoS One2013
23793043A novel high-resolution in vivo imaging technique to study the dynamic response of intracranial structures to tumor growth and therapeutics.J Vis Exp2013
23484491Investigations of antioxidant-mediated protection and mitigation of radiation-induced DNA damage and lipid peroxidation in murine skin.Int J Radiat Biol2013
23237541Mitigation of radiation-induced lung injury with EUK-207 and genistein: effects in adolescent rats.Radiat Res2013
23200673Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.Cancer Lett2013
23280784Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.Int J Cancer2013
22028038Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.Cancer2012
24213469Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx).Cancers (Basel)2012
22985778Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation.Radiother Oncol2012
23016737Special issue on radiation effects on stem cells and non-targeted effects of radiation.Int J Radiat Biol2012
22927920In vivo optical imaging of tumor and microvascular response to ionizing radiation.PLoS One2012
22465832Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer.Clin Cancer Res2012
  • 1 - 50 of 277

Recommended Authors

Jessica A Bertout
Fred Hutchinson Cancer Research Center
Career Start Year 2006
Number of shared co-authors 0
Daniela Schilling
Technical University of Munich (TUM)
Career Start Year 2005
Number of shared co-authors 2
Ludwig Dubois
Maastricht University
Career Start Year 2004
Number of shared co-authors 5
Natasja G Lieuwes
Maastricht University
Career Start Year 2003
Number of shared co-authors 4
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Sylvain V Costes
NASA Ames Research Center
Career Start Year 1999
Number of shared co-authors 0
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 6
Ranjit S Bindra
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 8
Johan Bussink
Radboud University, Nijmegen Medical Centre
Career Start Year 1995
Number of shared co-authors 5
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 4
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 14
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Stefan K??nemann
Switzerland Ecole Polytechnique Federal de Lausanne, EPFL
Career Start Year 1991
Number of shared co-authors 0
Heidi Lyng
Radiumhospitalet, Oslo University Hosptial
Career Start Year 1990
Number of shared co-authors 2
Silvia C Formenti
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Michael Henke
Medical Center, University of Freiburg
Career Start Year 1984
Number of shared co-authors 2
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 2
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 9
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 10
Catharine M L West
University of Manchester
Career Start Year 1981
Number of shared co-authors 6
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 1
Robert H Shoemaker
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 1
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 1
Peter J Selby
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 1
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 0
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Career Start Year 1974
Number of shared co-authors 4
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
John D Minna
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 4

Collaborators

Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 48
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 41
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 36
Robert G Bristow
University of Toronto
Co-authored papers 30
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 28
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 13
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 8
Jay S Wunder
University of Toronto
Co-authored papers 8
Blaise A Clarke
University of Toronto.
Co-authored papers 8
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 7
Stephen Chung
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Christine How
Ontario Cancer Institute, University Health Network (UHN)
Co-authored papers 4
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Co-authored papers 4
J. Martin Brown
Stanford University School of Medicine
Co-authored papers 4
Gelareh Zadeh
University of Toronto
Co-authored papers 4
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Simon N Powell
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Angela B Y Hui
Stanford University
Co-authored papers 3
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 3
Joerg Schwock
University of Toronto
Co-authored papers 3
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 3
Garth Powis
PHusis Therapeutics Inc.
Co-authored papers 3
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 3
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Rui Yan
University of Groningen, University Medical Center Groningen
Co-authored papers 2
Jeffrey Tze-Fei Wong
The Hong Kong University of Science and Technology
Co-authored papers 2
Thomas Helleday
The University of Sheffield
Co-authored papers 2
Masoom A Haider
University Health Network
Co-authored papers 2
Jennifer R Grandis
University of California san francisco
Co-authored papers 2
Release 1.2